Mexico Approves CBD Derivatives for Medical Use
Cancer patients will be allowed to import CBD products to relieve chemotherapy symptoms.
Published on February 13, 2017

A Mexican medical marijuana company has been granted permission to import CBD derivatives into the country in order to treat symptoms associated with cancer treatment. HempMeds Mexico will now be able to provide Real Scientific Hemp Oil-XTM to help a 44-year-old breast cancer patient deal with symptoms brought on by chemotherapy.

“This is a great opportunity to show the benefits that cannabinoids have as a solution to health conditions that haven’t met any result by traditional medical procedures,” said Carlos Gonzalez, Chief Operating Officer of HempMeds Mexico. “We hope that by using RSHO-X, this patient will carry a better quality of life after each chemotherapy treatment.”

HempMeds is currently the only company allowed to import medical marijuana products into the Mexico. Other patients who want to use CBD treatments must receive approval from their doctor and then obtain an import license from the Federal Commission for the Protection Against Sanitary Risk (COFEPRIS).

“We applaud and wholeheartedly stand by the decision made by COFEPRIS,” said Dr. Stuart Titus, CEO of Medical Marijuana, Inc., manufacturer of RSHO-X. “The decision made by Mexico to allow our subsidiary’s product to assist in the general well-being of this female patient sets the stage for a truly remarkable precedent. We encourage all others to follow the lead set out by COFEPRIS in utilizing our CBD Hemp Oil products as a step forward on the path towards alleviating pain.”

Chris Moore
Chris Moore is a New York-based writer who has written for Mass Appeal while also mixing records and producing electronic music.
Share this article with your friends!